{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:11:27Z","timestamp":1792559487904,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In addition to the role of skeletal muscle in movement and locomotion, muscle plays a critical role in a broad array of metabolic processes that can contribute to improved health or risk of disease. The age-associated loss of muscle has been termed sarcopenia. The muscle is the primary site of insulin-stimulated glucose disposal and the largest component of basal metabolic rate, directly and indirectly affects bone density, produces myokines with pleiotropic effect on muscle and other tissues including the brain, and stores essential amino acids essential for the maintenance of protein synthesis during periods of reduced food intake and stress. As such, not surprisingly deterioration of skeletal muscle health, typically operationalized as decline of muscle mass and muscle strength is both a powerful risk factor and main consequence of chronic diseases, disability, and loss of independence, and it is one of the strongest risk factors for mortality. However, skeletal muscle remains one of the most plastic of all tissues, with rapid changes in rates of protein synthesis and degradation in response to physical activity and inactivity, inflammation, and nutritional and hormonal status. This has made the development of pharmacological therapies to increase muscle mass (or prevent loss), an important goal for decades. However, while remarkable advances in the understanding of molecular and cellular regulation of muscle protein metabolism have occurred recently, there are no approved drugs for the treatment of sarcopenia, the loss of skeletal muscle affecting millions of older people. The goal of this paper is to describe the possible reasons for the lack of new and effective pharmacotherapies to treat one of the most important risk factors for age-associated disease and loss of independence.<\/jats:p>","DOI":"10.1007\/s11357-023-01016-9","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:02:31Z","timestamp":1700784151000},"page":"183-190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Sarcopenia: no consensus, no diagnostic criteria, and no approved indication\u2014How did we get here?"],"prefix":"10.1007","volume":"46","author":[{"given":"William J.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Guralnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Cawthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronenn","family":"Roubenoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"1016_CR1","first-page":"5","volume":"50","author":"WJ Evans","year":"1995","unstructured":"Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci Spec. 1995;50:5\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci Spec"},{"key":"1016_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/epirev\/mxs006","volume":"35","author":"LA Schaap","year":"2013","unstructured":"Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev. 2013;35:51\u201365.","journal-title":"Epidemiol Rev"},{"issue":"6","key":"1016_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/gerona\/gly129","volume":"74","author":"PM Cawthon","year":"2019","unstructured":"Cawthon PM, Orwoll ES, Peters KE, et al. Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men. J Gerontol A Biol Sci Med Sci. 2019;74(6):844\u201352.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1016_CR4","doi-asserted-by":"crossref","unstructured":"Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM. The importance of muscle versus fat mass in sarcopenic obesity: a re-evaluation using D3-creatine muscle mass versus DXA lean mass measurements. J Gerontol A Biol Sci Med Sci. 2020;75(7):1362\u20138.","DOI":"10.1093\/gerona\/glaa064"},{"issue":"1","key":"1016_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1748-1716.1990.tb08974.x","volume":"140","author":"H Klitgaard","year":"1990","unstructured":"Klitgaard H, Mantoni M, Schiaffino S, et al. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 1990;140(1):41\u201354.","journal-title":"Acta Physiol Scand"},{"issue":"1","key":"1016_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1152\/physrev.00061.2017","volume":"99","author":"L Larsson","year":"2019","unstructured":"Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99(1):427\u2013511.","journal-title":"Physiol Rev"},{"key":"1016_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1748-1716.1983.tb00024.x","volume":"117","author":"L Larsson","year":"1983","unstructured":"Larsson L. Histochemical characteristics of human skeletal muscle during aging. Acat Physiol Scand. 1983;117:469\u201371.","journal-title":"Acat Physiol Scand"},{"key":"1016_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1152\/jappl.1978.45.4.536","volume":"33","author":"SP Tzankoff","year":"1978","unstructured":"Tzankoff SP, Norris AH. Longitudinal changes in basal metabolic rate in man. J Appl Physiol. 1978;33:536\u20139.","journal-title":"J Appl Physiol"},{"issue":"4","key":"1016_CR9","doi-asserted-by":"publisher","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","volume":"91","author":"WJ Evans","year":"2010","unstructured":"Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr. 2010;91(4):1123S-S1127.","journal-title":"Am J Clin Nutr"},{"issue":"16","key":"1016_CR10","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/jama.297.16.1772-b","volume":"297","author":"P Kortebein","year":"2007","unstructured":"Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297(16):1772\u20134.","journal-title":"JAMA"},{"issue":"9","key":"1016_CR11","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1210\/jc.2003-032159","volume":"89","author":"D Paddon-Jones","year":"2004","unstructured":"Paddon-Jones D, Sheffield-Moore M, Urban RJ, et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab. 2004;89(9):4351\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"1016_CR12","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1113\/JP270699","volume":"593","author":"RE Tanner","year":"2015","unstructured":"Tanner RE, Brunker LB, Agergaard J, et al. Age-related differences in lean mass, protein synthesis and skeletal muscle markers of proteolysis after bed rest and exercise rehabilitation. J Physiol. 2015;593(18):4259\u201373.","journal-title":"J Physiol"},{"issue":"1","key":"1016_CR13","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1038\/s41467-023-39786-7","volume":"14","author":"Y Rolland","year":"2023","unstructured":"Rolland Y, Sierra F, Ferrucci L, et al. Challenges in developing Geroscience trials. Nat Commun. 2023;14(1):5038.","journal-title":"Nat Commun"},{"issue":"1","key":"1016_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"2","key":"1016_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95\u2013101.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"1016_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547\u201358.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"1016_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","volume":"51","author":"AB Newman","year":"2003","unstructured":"Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51(11):1602\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"1016_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","volume":"147","author":"RN Baumgartner","year":"1998","unstructured":"Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755\u201363.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1016_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","volume":"50","author":"I Janssen","year":"2002","unstructured":"Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889\u201396.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1016_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249\u201356.","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"1016_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jgs.16372","volume":"68","author":"S Bhasin","year":"2020","unstructured":"Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020;68(7):1410\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1016_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0749-3797(03)00197-1","volume":"25","author":"EM Castillo","year":"2003","unstructured":"Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2003;25(3):226\u201331.","journal-title":"Am J Prev Med"},{"issue":"5","key":"1016_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1532-5415.2007.01140.x","volume":"55","author":"MJ Delmonico","year":"2007","unstructured":"Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55(5):769\u201374.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1016_CR24","doi-asserted-by":"publisher","first-page":"M772","DOI":"10.1093\/gerona\/57.12.M772","volume":"57","author":"M Iannuzzi-Sucich","year":"2002","unstructured":"Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57(12):M772\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"1016_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","volume":"12","author":"JE Morley","year":"2011","unstructured":"Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12(6):403\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1016_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/jgs.16823","volume":"69","author":"AJ Mayhew","year":"2021","unstructured":"Mayhew AJ, Phillips SM, Sohel N, et al. Do different ascertainment techniques identify the same individuals as sarcopenic in the Canadian Longitudinal Study on Aging? J Am Geriatr Soc. 2021;69(1):164\u201372.","journal-title":"J Am Geriatr Soc"},{"key":"1016_CR27","doi-asserted-by":"crossref","unstructured":"Cawthon PM, Visser M, Arai H, et al. Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med. 2022;13(6):1239\u201344.","DOI":"10.1007\/s41999-022-00706-5"},{"key":"1016_CR28","doi-asserted-by":"crossref","unstructured":"Guralnik J, Cawthon P, Bhasin S, et al. Limited physician knowledge of sarcopenia: a survey. JAGS. 2023;71(5):1595\u2013602.","DOI":"10.1111\/jgs.18227"},{"issue":"10","key":"1016_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","volume":"61","author":"BH Goodpaster","year":"2006","unstructured":"Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059\u201364.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1016_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcsm.12494","volume":"11","author":"KA Duchowny","year":"2020","unstructured":"Duchowny KA, Peters KE, Cummings SR, et al. Association of change in muscle mass assessed by D3 -creatine dilution with changes in grip strength and walking speed. J Cachexia Sarcopenia Muscle. 2020;11(1):55\u201361.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1016_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/gerona\/glr010","volume":"67","author":"TM Manini","year":"2012","unstructured":"Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67(1):28\u201340.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"1016_CR32","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/ageing\/afab148","volume":"50","author":"PR Carvalho do Nascimento","year":"2021","unstructured":"Carvalho do Nascimento PR, Bilodeau M, Poitras S. How do we define and measure sarcopenia? A meta-analysis of observational studies. Age Ageing. 2021;50(6):1906\u201313.","journal-title":"Age Ageing"},{"key":"1016_CR33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199503023320902","volume":"332","author":"JM Guralnik","year":"1995","unstructured":"Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556\u201361.","journal-title":"N Engl J Med"},{"key":"1016_CR34","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Wallace RB. Short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85\u201394.","journal-title":"J Gerontol"},{"issue":"1","key":"1016_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jama.2010.1923","volume":"305","author":"S Studenski","year":"2011","unstructured":"Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50\u20138.","journal-title":"JAMA"},{"issue":"2","key":"1016_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1123\/japa.2013-0236","volume":"23","author":"A Middleton","year":"2015","unstructured":"Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015;23(2):314\u201322.","journal-title":"J Aging Phys Act"},{"issue":"2","key":"1016_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528\u201338.","journal-title":"Cancer"},{"key":"1016_CR38","doi-asserted-by":"publisher","first-page":"e068788","DOI":"10.1136\/bmj-2021-068788","volume":"377","author":"R Bernabei","year":"2022","unstructured":"Bernabei R, Landi F, Calvani R, et al. Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). BMJ. 2022;377:e068788.","journal-title":"BMJ"},{"issue":"25","key":"1016_CR39","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1056\/NEJM199406233302501","volume":"330","author":"MA Fiatarone","year":"1994","unstructured":"Fiatarone MA, O\u2019Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25):1769\u201375.","journal-title":"N Engl J Med"},{"key":"1016_CR40","unstructured":"Forbes. https:\/\/www.forbes.com\/companies\/alzheimers-association\/?sh=78d1e5c012b9."},{"key":"1016_CR41","unstructured":"Cubanski J, Newman T, Freed M. The facts on Medicare spending and financing. https:\/\/files.kff.org\/attachment\/Issue-Brief-Facts-on-Medicaid-Spending-and-Financing: Kaiser Family Foundaton, 2019."},{"issue":"4","key":"1016_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/gerona\/gln042","volume":"64","author":"S Bhasin","year":"2009","unstructured":"Working Group on Functional Outcome Measures for Clinical T, Bhasin S, Espeland MA, et al. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009;64(4):487\u201391.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"13","key":"1016_CR43","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1080\/14656566.2019.1622093","volume":"20","author":"JP Hardee","year":"2019","unstructured":"Hardee JP, Lynch GS. Current pharmacotherapies for sarcopenia. Expert Opin Pharmacother. 2019;20(13):1645\u201357.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1016_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1152\/jappl.1977.43.6.1001","volume":"43","author":"SP Tzankoff","year":"1977","unstructured":"Tzankoff SP, Norris AH. Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol Respir Environ Exerc Physiol. 1977;43(6):1001\u20136.","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"issue":"3","key":"1016_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1152\/jappl.1988.65.3.1147","volume":"65","author":"JL Fleg","year":"1988","unstructured":"Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol. 1988;65(3):1147\u201351.","journal-title":"J Appl Physiol"},{"key":"1016_CR46","doi-asserted-by":"crossref","unstructured":"Cawthon PM, Peters KE, Cummings SR, et al. Association between muscle mass determined by D3-creatine dilution and incident fractures in a prospective cohort study of older men. J Bone Miner Res. 2022;37(7):1213\u201320.","DOI":"10.1002\/jbmr.4505"},{"key":"1016_CR47","doi-asserted-by":"crossref","unstructured":"Cawthon PM, Blackwell T, Cummings SR, et al. Muscle mass assessed by D3-creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community dwelling older men. J Gerontol A Biol Sci Med Sci. 2020;76(1):123\u201330.","DOI":"10.1093\/gerona\/glaa111"},{"issue":"12","key":"1016_CR48","doi-asserted-by":"publisher","first-page":"e0278723","DOI":"10.1371\/journal.pone.0278723","volume":"17","author":"HR Banack","year":"2022","unstructured":"Banack HR, LaMonte MJ, Manson JE, et al. Association of muscle mass measured by D3-Creatine (D3Cr), sarcopenic obesity, and insulin-glucose homeostasis in postmenopausal women. PLoS ONE. 2022;17(12):e0278723.","journal-title":"PLoS ONE"},{"issue":"6","key":"1016_CR49","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s41999-019-00232-x","volume":"10","author":"T Erdogan","year":"2019","unstructured":"Erdogan T, Bahat G, Kilic C, et al. The relationship between sarcopenia and urinary incontinence. Eur Geriatr Med. 2019;10(6):923\u20139.","journal-title":"Eur Geriatr Med"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-01016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-023-01016-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-01016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T09:23:50Z","timestamp":1706606630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-023-01016-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s11357-023-01016-9","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WJE is a consultant for BioAge Labs, Inc. He works with MyoCorps, Inc. PC is a consultant for MyoCorps, Inc. All other authors report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}